Affiliation:
1. Department of Biology and Biomedical Research Institute, University of York, York YO10 5DD, UK
2. Programa de Pós Graduação em, Ciências Biológicas, Universidade Federal de Ouro Preto, Ouro Preto 35402-136 , Brazil
Abstract
After many decades of research, a schistosome vaccine still looks to be a distant prospect. These helminths can live in the human bloodstream for years, even decades, surrounded by and feeding on the components of the immune response they provoke. The original idea of a vaccine based on the killing of invading cercariae in the skin has proven to be illusory. There has also been a realisation that even if humans develop some protection against infection over a protracted period, it very likely involves IgE-mediated responses that cannot provide the basis for a vaccine. However, it has also become clear that both invasive migrating larvae and adult worms must expose proteins and release secretions into the host environment as part of their normal biological activities. The application of modern ‘omics approaches means that we now have a much better idea of the identity of these potential immune targets. This review looks at three animal models in which acquired immunity has been demonstrated and asks whether the mechanisms might inform our vaccine strategies to achieve protection in model hosts and humans. Eliciting responses, either humoral or cellular, that can persist for many months is a challenge. Arming of the lungs with effector T cells, as occurs in mice exposed to the radiation-attenuated cercarial vaccine, is one avenue. Generating IgG antibody titres that reach levels at which they can exert sustained immune pressure to cause worm elimination, as occurs in rhesus macaques, is another. The induction of memory cell populations that can detect trickle invasions of larval stages remains to be explored. One promising approach is the analysis of protective antibodies using high-density peptide arrays of target proteins to identify reactive regions. These can be combined in multi-epitope constructs to immunise a host against many targets simultaneously and cheaply.
Subject
Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,Molecular Biology,Immunology and Allergy
Reference89 articles.
1. Schistosomiasis mansoni in Yemeni in California: Duration of infection, presence of disease, therapeutic management;Warren;Am. J. Trop. Med. Hyg.,1974
2. A review of schistosomiasis in immigrants in Western Australia, demonstrating the unusual longevity of Schistosoma mansoni;Harris;Trans. R. Soc. Trop. Med. Hyg.,1984
3. Dynamics of Schistosoma haematobium infection in a Gambian community. III. Acquisition and loss of infection;Wilkins;Trans R Soc Trop Med Hyg.,1984
4. Immunological aspects of human schistosomiasis;Butterworth;Br. Med. Bull.,1998
5. Fitzsimmons, C.M., Jones, F.M., Stearn, A., Chalmers, I.W., Hoffmann, K.F., Wawrzyniak, J., Wilson, S., Kabatereine, N.B., and Dunne, D.W. (2012). The Schistosoma mansoni tegumental-allergen-like (TAL) protein family: Influence of developmental expression on human IgE responses. PLoS Negl. Trop. Dis., 6.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献